Filing Details

Accession Number:
0000899243-19-012935
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-09 20:04:48
Reporting Period:
2019-05-07
Accepted Time:
2019-05-09 20:04:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1351288 Gw Pharmaceuticals Plc GWPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754239 D. Adam George Sovereign House, Vision Park, Histon
Cambridge X0 CB24 9BZ
Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-05-07 258,324 $0.00 268,324 No 4 M Direct
Ordinary Shares Disposition 2019-05-07 258,324 $16.10 10,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Options Disposition 2019-05-07 31,144 $0.00 31,144 $0.00
Ordinary Shares Stock Options Disposition 2019-05-07 39,121 $0.00 39,121 $0.00
Ordinary Shares Stock Options Disposition 2019-05-07 46,071 $0.00 46,071 $0.00
Ordinary Shares Stock Options Disposition 2019-05-07 59,128 $0.00 59,128 $0.00
Ordinary Shares Stock Options Disposition 2019-05-07 69,924 $0.00 69,924 $0.00
Ordinary Shares Stock Options Disposition 2019-05-07 12,936 $0.00 12,936 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-07-19 No 4 M Direct
0 2023-09-24 No 4 M Direct
0 2024-08-12 No 4 M Direct
3,620 2025-06-24 No 4 M Direct
97,018 2026-02-15 No 4 M Direct
99,180 2027-01-06 No 4 M Direct
Footnotes
  1. Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
  2. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of May 7, 2019.
  3. Represented by ADSs. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2019.
  4. The exercise price reported is price per ordinary share converted from price per ADS.
  5. Granted pursuant to the Issuer's Enterprise Management Incentive Scheme and fully vested.
  6. Granted pursuant to the Issuer's Long-Term Incentive Plan and fully vested.
  7. Granted pursuant to the Issuer's Long-Term Incentive Plan, of which 3,620 shares will vest on June 24, 2019 and the rest have vested.
  8. Granted pursuant to the Issuer's Long-Term Incentive Plan, of which 9,632 shares will vest on February 15, 2020, and the rest have vested.
  9. Granted pursuant to the Issuer's Long-Term Incentive Plan, of which 92,712 shares will vest on January 6, 2020, 6,468 shares will vest on January 6, 2021 and the rest have vested